Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Results from Phase 2b Dry Eye Disease Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. SPY
4. IQMX
5. EROC
6. MSTR
7. NVDA
8. TSLA
9. MSFT
10. SEER

Go back to Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Results from Phase 2b Dry Eye Disease Clinical Trial

Aldeyra Therapeutics (ALDX) Set to Up Higher by 60% Following Positive Results from Phase 2b Dry Eye Disease Clinical Trial

September 26, 2018 7:33 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) Set to Up Higher by 60% Following Positive Results from Phase 2b Dry Eye Disease Clinical Trial

... More